Provided by Tiger Fintech (Singapore) Pte. Ltd.

Obalon Therapeutics Inc

3.05
+0.0000
Volume:- -
Turnover:- -
Market Cap:10.19M
PE:-0.74
High:3.05
Open:3.05
Low:3.05
Close:3.05
Loading ...
Jun 30, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 30, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 25, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 21, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 15, 2021

Major Issues Report

8-K - Current report
Jun 15, 2021

Major Issues Report

8-K - Current report
May 26, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 18, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 18, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 18, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2021

Major Issues Report

8-K - Current report
May 04, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 04, 2021

Major Issues Report

8-K - Current report
Apr 09, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 15, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership